Vilobelimab is a first-in-class anti-human complement factor C5a monoclonal antibody. The Food and Drug Administration (FDA) has granted Fast Track designation to vilobelimab for the treatment of ...

Studies of the epidemiology of acute glomerulonephritis (AGN) following pyoderma reported over the past 15 years have been reviewed. Investigations in Alabama, at Red Lake in Minnesota, and in ...

RITTER'S disease, exfoliative dermatitis of the newborn, was first described by Ritter von Ritter-shain in 1878. Many investigators, since the work of Winternitz, 1 in 1898, suggested Staphylococcus ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Ulcerative pyoderma gangrenosum is a rare disease with ...

For months, an experimental medication has kept him alive, but the clinical trial that provided it is losing its funding.